Palliative radiotherapy near the end of life : An analysis of factors influencing the administration of radiotherapy in advanced tumor disease

Article

LE, Nguyen-Son | ZEYBEK, Asli | HACKNER, Klaus | GALLAUNER, Cornelia | SINGER, Josef | SCHRAGEL, Felix | GEORG, Petra | GOTTSAUNER-WOLF, Sandra | PECHERSTORFER, Martin | KREYE, Gudrun

PURPOSE: Palliative radiotherapy (PRT) toward the end of life (EOL) in advanced tumor disease is contentious. Although EOL RT can alleviate cancer-related symptoms, relief typically occurs weeks to months after treatment, potentially compromising the quality of life of patients during the final stages. This study aims to assess factors influencing the decision-making process regarding EOL RT. MATERIALS AND METHODS: This retrospective study of a real-world cohort included 684 consecutive patients with a diagnosis of a solid tumor who died between 2017 and 2021. In these patients, factors potentially influencing the administration of EOL RT were analyzed. RESULTS: Of the 684 patients, 164 received PRT, with 60 (36.6%) receiving EOL RT within the last 30 days of life. The median time from the last RT session to death was 55 days. Significant factors influencing EOL RT administration were age {:zz2264}65 years (odds ratio [OR], 1.75 [95% CI, 1.02 to 3.01]), Union for International Cancer Control stage IV (OR, 2.77 [95% CI, 1.41 to 5.46]), lung cancer (OR, 2.16 [95% CI, 1.00 to 4.68]), palliative care referral (OR, 1.80 [95% CI, 0.98 to 3.30]), systemic anticancer treatment {:zz2264}30 days before death (OR, 1.87 [95% CI, 1.05 to 3.33]), and Eastern Cooperative Oncology Group performance status {:zz2265}2 (OR, 3.73 [95% CI, 1.88 to 7.40]). Furthermore, RT near the EOL was more likely administered at multiple sites (OR, 2.08 [95% CI, 1.00 to 4.29]) and with {:zz2264}5 fractions (OR, 2.37 [95% CI, 1.23 to 4.57]), while being associated with lower response rates (OR, 0.43 [95% CI, 0.21 to 0.86]) and increased therapy discontinuation (OR, 4.40 [95% CI, 1.45 to 13.37]). CONCLUSION: These findings highlight varying RT patterns influenced by specific factors, demonstrating the complexity of EOL treatment decisions in advanced cancer care. Identifying key factors for personalized, patient-centered EOL RT decisions warrants further investigation.

http://dx.doi.org/10.1200/GO-24-00500

Voir la revue «JCO global oncology, 11»

Autres numéros de la revue «JCO global oncology»

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Gestion